Jeffrey Lee
Kaiser Permanente
Appearances
- DateMay 8, 2023Review updates and current considerations in colon cancer screening and surveillance related topics…
Moderators
New York UniversityKaiser Permanente - DateMay 7, 2023BACKGROUND: Novel treatment options for eosinophilic esophagitis (EoE) are needed. Previous studies have assessed mepolizumab (mepo), a monoclonal antibody against IL-5, with mixed results in EoE, and the efficacy of mepo in an adult and adolescent population has yet to be fully examined…
Presenters
Speakers
Kaiser PermanenteUniversity of North Carolina School of MedicineAmsterdam UMC, University of AmsterdamMount Sinai School of MedicineNorthwestern University - The Feinberg School of Medicine - DateMay 8, 2023Early-onset colorectal cancer (CRC diagnosed before age 50) has risen worldwide, with an increasing number of survivors of reproductive age. We aimed to investigate the risk of adverse pregnancy and neonatal outcomes among early-onset CRC survivors…
Presenter
Speakers
- DateMay 20, 2024SOCIETY: AGA Multiple areas of colon cancer screening are evolving rapidly. These include effectiveness, AI, positioning of noninvasive testing and optimal management of sessile serrated lesions. This session will incorporate international experts to address these questions…
Moderators
Kaiser PermanenteUniversity of Colorado, Rocky Mountain Regional VA - DateMay 19, 2024Early-onset colorectal cancer (EOCRC, i.e., CRC diagnosed <50 years) has increased dramatically over the past three decades. However, little is known about what may be driving this alarming trend…
Presenter
Speakers
- DateMay 21, 2024BACKGROUND: Prior guidelines recommended initiating colorectal cancer (CRC) screening for average-risk individuals at age 50 years; however, recent guidelines have made qualified recommendations to initiate screening at age 45…
- DateMay 18, 2024SOCIETY: AGA CRC screening and surveillance
Moderators
New York UniversityKaiser PermanenteSpeakers
University of California San Diego